• myGriffith
    • Staff portal
    • Contact Us⌄
      • Future student enquiries 1800 677 728
      • Current student enquiries 1800 154 055
      • International enquiries +61 7 3735 6425
      • General enquiries 07 3735 7111
      • Online enquiries
      • Staff phonebook
    View Item 
    •   Home
    • Griffith Research Online
    • Journal articles
    • View Item
    • Home
    • Griffith Research Online
    • Journal articles
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

  • All of Griffith Research Online
    • Communities & Collections
    • Authors
    • By Issue Date
    • Titles
  • This Collection
    • Authors
    • By Issue Date
    • Titles
  • Statistics

  • Most Popular Items
  • Statistics by Country
  • Most Popular Authors
  • Support

  • Contact us
  • FAQs
  • Admin login

  • Login
  • A randomized, controlled pilot clinical trial of cryopreserved platelets for perioperative surgical bleeding: the CLIP-I trial

    Author(s)
    Reade, MC
    Marks, DC
    Bellomo, R
    Deans, R
    Faulke, DJ
    Fraser, JF
    Gattas, DJ
    Holley, AD
    Irving, DO
    Johnson, L
    Pearse, BL
    Royse, AG
    Wong, J
    Weinberg, L
    Eastwood, G
    Peck, L
    Young, H
    Sidiropoulos, S
    Baulch, S
    Dalyell, A
    Kolar, D
    Martinelli, T
    Reidy, Y
    Caldwell, N
    Tivendale, L
    Bisignano, M
    Hausler, M
    Williams, Z
    Dong, N
    Buhr, H
    Bannon, P
    Cartwright, B
    Turner, L
    Gibson, J
    Blayney, B
    Beattie, L
    Hutch, D
    Wun Jennifer Coles, J
    Pearse, B
    Faulke, D
    Zeigenfuss, M
    Tesar, P
    Fraser, J
    Perel, J
    Kahn, C
    Vincent, B
    O'Brien, D
    Irving, D
    Griffith University Author(s)
    Fraser, John F.
    Pearse, Bronwyn L.
    Year published
    2019
    Metadata
    Show full item record
    Abstract
    BACKGROUND: Cryopreservation extends platelet (PLT) shelf life from 5 to 7 days to 2 to 4 years. However, only 73 patients have been transfused cryopreserved PLTs in published randomized controlled trials (RCTs), making safety data insufficient for regulatory approval. STUDY DESIGN AND METHODS: The Cryopreserved vs. Liquid Platelet (CLIP) study was a double‐blind, pilot, multicenter RCT involving high‐risk cardiothoracic surgical patients in four Australian hospitals. The objective was to test, as the primary outcome, the feasibility and safety of the protocol. Patients were allocated to study group by permuted block ...
    View more >
    BACKGROUND: Cryopreservation extends platelet (PLT) shelf life from 5 to 7 days to 2 to 4 years. However, only 73 patients have been transfused cryopreserved PLTs in published randomized controlled trials (RCTs), making safety data insufficient for regulatory approval. STUDY DESIGN AND METHODS: The Cryopreserved vs. Liquid Platelet (CLIP) study was a double‐blind, pilot, multicenter RCT involving high‐risk cardiothoracic surgical patients in four Australian hospitals. The objective was to test, as the primary outcome, the feasibility and safety of the protocol. Patients were allocated to study group by permuted block randomization, with patients and clinicians blinded by use of an opaque shroud placed over each study PLT unit. Up to 3 units of cryopreserved or liquid‐stored PLTs were administered per patient. No other aspect of patient care was affected. Adverse events were actively sought. RESULTS: A total of 121 patients were randomized, of whom 23 received cryopreserved PLTs and 18 received liquid‐stored PLTs. There were no differences in blood loss (median, 715 mL vs. 805 mL at 24 hr; difference between groups 90 mL [95% CI, –343.8 to 163.8 mL], p = 0.41), but the Bleeding Academic Research Consortium criterion for significant postoperative hemorrhage in cardiac surgery composite bleeding endpoint occurred in nearly twice as many patients in the liquid‐stored group (55.6% vs. 30.4%, p = 0.10). Red blood cell transfusion requirements were a median of 3 units in the cryopreserved group versus 4 units with liquid‐stored PLTs (difference between groups, 1 unit [95% CI, –3.1 to 1.1 units]; p = 0.23). Patients in the cryopreserved group were more likely to be transfused fresh‐frozen plasma (78.3% vs. 27.8%, p = 0.002) and received more study PLT units (median, 2 units vs. 1 unit; difference between groups, 1 unit [95% CI, –0.03 to 2.0 units]; p = 0.012). There were no between‐group differences in potential harms including deep venous thrombosis, myocardial infarction, respiratory function, infection, and renal function. No patient had died at 28 days, and postoperative length of stay was similar in each group. CONCLUSION: In this pilot RCT, compared to liquid‐stored PLTs, cryopreserved PLTs were associated with no evidence of harm. A definitive study testing safety and hemostatic effectiveness is warranted.
    View less >
    Journal Title
    Transfusion
    DOI
    https://doi.org/10.1111/trf.15423
    Note
    This publication has been entered into Griffith Research Online as an Advanced Online Version.
    Subject
    Cardiorespiratory Medicine and Haematology
    Clinical Sciences
    Immunology
    Publication URI
    http://hdl.handle.net/10072/386799
    Collection
    • Journal articles

    Footer

    Disclaimer

    • Privacy policy
    • Copyright matters
    • CRICOS Provider - 00233E

    Tagline

    • Gold Coast
    • Logan
    • Brisbane - Queensland, Australia
    First Peoples of Australia
    • Aboriginal
    • Torres Strait Islander